Stifel Nicolaus Increases Celsius (NASDAQ:CELH) Price Target to $56.00

Key Points

• Stifel Nicolaus has raised Celsius's price target from $50.00 to $56.00, maintaining a "buy" rating and indicating a potential upside of 7.17% from the previous close.
• In contrast to Stifel's outlook, Bank of America has downgraded the stock with an underperform rating and a target of $40.00.
• Major shareholders, William H. Milmoe and Deborah Desantis, each sold 100,000 shares at a price of $47.50, resulting in a total transaction of $4.75 million each.

Celsius (NASDAQ:CELH - Free Report) had its target price hoisted by Stifel Nicolaus from $50.00 to $56.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have a buy rating on the stock.

CELH has been the topic of a number of other research reports. Bank of America lifted their price target on shares of Celsius from $35.00 to $40.00 and gave the company an "underperform" rating in a research note on Friday. Roth Capital reissued a "buy" rating and issued a $52.00 price target (up previously from $46.00) on shares of Celsius in a research note on Thursday, June 26th. UBS Group lifted their target price on shares of Celsius from $49.00 to $57.00 and gave the stock a "buy" rating in a research note on Thursday, July 17th. TD Cowen raised shares of Celsius from a "hold" rating to a "buy" rating and lifted their target price for the stock from $37.00 to $55.00 in a research note on Monday, June 16th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Celsius from $44.00 to $54.00 and gave the stock an "overweight" rating in a research note on Thursday, July 31st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $51.72.

Celsius Price Performance

Celsius stock traded up $1.83 during trading on Friday, reaching $51.95. The company had a trading volume of 10,291,968 shares, compared to its average volume of 6,108,101. The firm's 50-day simple moving average is $44.51 and its 200 day simple moving average is $36.13. Celsius has a 1-year low of $21.10 and a 1-year high of $53.85. The firm has a market capitalization of $13.39 billion, a PE ratio of 140.41, a price-to-earnings-growth ratio of 1.81 and a beta of 1.40. The company has a debt-to-equity ratio of 0.68, a quick ratio of 3.04 and a current ratio of 2.11.

Celsius (NASDAQ:CELH - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.47 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.24. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The firm had revenue of $739.30 million for the quarter, compared to analysts' expectations of $632.13 million. During the same quarter last year, the company earned $0.28 EPS. The firm's revenue for the quarter was up 83.9% compared to the same quarter last year. As a group, equities research analysts anticipate that Celsius will post 0.89 earnings per share for the current fiscal year.

Insider Activity at Celsius

In other Celsius news, major shareholder Deborah Desantis sold 100,000 shares of the business's stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $47.50, for a total transaction of $4,750,000.00. Following the sale, the insider directly owned 17,717,770 shares in the company, valued at $841,594,075. This represents a 0.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO John Fieldly sold 143,167 shares of the business's stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $51.18, for a total transaction of $7,327,287.06. Following the sale, the chief executive officer owned 895,410 shares in the company, valued at $45,827,083.80. This trade represents a 13.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 1,106,141 shares of company stock worth $51,985,705. Company insiders own 2.55% of the company's stock.

Institutional Trading of Celsius

Institutional investors and hedge funds have recently bought and sold shares of the business. Triumph Capital Management increased its stake in Celsius by 41.5% during the fourth quarter. Triumph Capital Management now owns 40,420 shares of the company's stock worth $1,065,000 after purchasing an additional 11,863 shares during the period. Fifth Third Bancorp increased its stake in Celsius by 62.9% during the first quarter. Fifth Third Bancorp now owns 1,725 shares of the company's stock worth $61,000 after purchasing an additional 666 shares during the period. GAMMA Investing LLC increased its stake in Celsius by 4,164.4% during the first quarter. GAMMA Investing LLC now owns 73,092 shares of the company's stock worth $2,604,000 after purchasing an additional 71,378 shares during the period. Oppenheimer & Co. Inc. increased its stake in shares of Celsius by 14.0% during the first quarter. Oppenheimer & Co. Inc. now owns 9,760 shares of the company's stock worth $348,000 after buying an additional 1,199 shares during the period. Finally, Cambridge Investment Research Advisors Inc. increased its stake in shares of Celsius by 21.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 45,517 shares of the company's stock worth $1,621,000 after buying an additional 8,009 shares during the period. 60.95% of the stock is currently owned by hedge funds and other institutional investors.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.